New Report Dissects Insulin Delivery System Markets

A report by Frost & Sullivan, U.S. Diabetes Insulin Delivery Systems Markets, examines the delivery devices that facilitate the self-administration of insulin. In 1997, market revenues totaled $236 million, representing a 6.6 percent increase from the previous year.

75 percent of total revenues from this market come as a result of the sale of Insulin syringes. Sea Joon Kim, medical analyst at Frost & Sullivan, believes the reason for this is the insulin syringe's ability to offer flexibility in the customization of patient therapy. "When you combine that with their significantly lower price, it is easy to understand why syringes have been able to create such a commanding presence over other methods of delivery," he adds.

Further, the study reports that several companies are developing other delivery options, most notably, the insulin pump device segment, which is significantly more expensive, but provides patients with enhanced blood glucose control as the product continuously supplies the body with the proper amounts of insulin.

The study provides detailed analyses of the following segments of the U.S. delivery system markets: Diabetes Insulin Syringe Market, Diabetes Jet Injection Devices Market, Diabetes Insertion Aid Devices Market, Diabetes Insulin Pen Devices Market, Diabetes Insulin Pen Needles Market, Diabetes Insulin Pump Devices Market.

Frost & Sullivan is an international marketing consulting company that monitors the medical industry for market trends, market measurements, and strategies

For more information: Keith Hammond, Frost & Sullivan. Tel: 650-237-4384.